期刊文献+

过敏性紫癜患者急性期淋巴细胞亚群和体液免疫功能的检测 被引量:10

Detection of Blood Lymphocyte Subgroup and Immunoglobulin Level of Henoch-Schonlein Purpura Patient in Acute Phase
暂未订购
导出
摘要 目的探讨过敏性紫癜(HSP)患者急性期的外周淋巴细胞免疫、体液免疫变化及其在HSP发病机制中的意义。方法采用流式细胞术(FCM)对35例HSP急性期患者外周血淋巴细胞及其亚群细胞进行定量检测;应用免疫比浊法对其外周血清免疫球蛋白及补体进行定量检测。结果HSP急性期患者CD4+,CD4+/CD8+,CD16+56+细胞均显著低于健康对照组(P<0.05,P<0.01,P<0.01),而CD19+细胞明显高于健康对照组(P<0.01),免疫球蛋白IgA含量高于健康对照组(P<0.01),均有统计学意义。结论HSP患者急性期存在细胞免疫功能及体液免疫失调,且与病情相关。提示可加用免疫调节剂治疗。 Objective To observe the changes of the functional states of lymphocyte subgroup and immunoglobulin level of patients with Henoch-Sehonlein(HSP) in aeute phase, and to explore their roles in the pathogenesis of HSP. Methods The immunoglobulin concentration was detected with nephelometer and lymphocyte subgroup CD3^+ , CD4 ^+ , CD8^+ , CD4^+ /CD8^+ , CD19^+ , CD16+56^+ level of acute state with tlow cytometry (FCM) . Results The contents of CD4^+ in actue state, ratio of CD4 ^+ /CD8^+ , CD16 + 56^+ cell were lower than that in control group( P 〈 0.05, P 〈 0. 01, P 〈 0.01 ) ; CD19^+ cell were higher than that in control group (P 〈 0.01) . IgA concentration was significantly higher than that in control gruup. Conclusion There are abnormal changes in body fluid immunity and cell immunity in HSP aetue state,and related with progress of the ill.The immune regulation therapy can he used in routine.
出处 《潍坊医学院学报》 2006年第6期421-422,共2页 Acta Academiae Medicinae Weifang
关键词 紫癜 过敏性 流式细胞术 淋巴细胞亚群 免疫球蛋白 Purpura Henock- schonlein FCM Lymphocyte subsets hnmunoglobin
  • 相关文献

参考文献6

二级参考文献27

  • 1高玉兴,池永学,李亚荣,尹永杰,刘禹仁.过敏性紫癜白细胞介素2水平及其受体表达[J].中华儿科杂志,1995,33(2):91-92. 被引量:39
  • 2姜新猷,南京医学院学报,1982年,2卷,26页
  • 3杨贵贞,免疫生物工程纲要与技术,1991年
  • 4Egan CA, Taylor TB, Meyer LJ, et al. IgA1 is the major IgA subclass in cutaneous blood vessels in Henoch-Schnolein purpura[J].Br J Dermatol, 1999,14(5):859-862.
  • 5Sediva A. Stejskal J, Bartunkova, J, et al. Detection of alpha(beta)-N-acetyl-D-galactosamine-binding sites in kidney-relation to Henoch- Schonlein-associated IgA nephropathy[J]. Folia Biol (Praha),1999,45(4):147-150.
  • 6Moja P, Quesnel A, Resseguier V, et al. Is there IgA form gut mucosal origin in the serum of children with Henoch-Schonlein Purpura?[J].Clin Immunol Immunopathol, 1998,86(3):290-297.
  • 7Davin JC, Pierard G, Dechenne C, et al. Possible pathogenic role of IgE in Hennoch-Schonlein purpura[J]. Pediatr Nephrol, 1994,8(2):169-171.
  • 8Fujieda M, Oishi N, Naruse K, et al. Soluble thrombomodulin and antibodies to bovineglomemlarendothelial cells in patients with HenochSchonlein purpura[J]. Arch Dis Child, 1998,78(3):240-244.
  • 9Yang YH, Huang MT, Lin SC, et al. Increased transforming growth factor- beta (TGF- beta)-secreting T cells and IgA anti-cardiolipin antibody levels during acute stage of childhood Henoch-Schonlein purpura[J]. Clin Exp Immunol, 2000,122(2):285-290.
  • 10Sokol DK, Mclntyre JA, short RA, et al. Henoch-Schonlein purpura and stroke: antiphosphatidylethanolamine antibody in CSF and serum[J]. Neurology, 2000,55(9):1379-1381.

共引文献116

同被引文献72

引证文献10

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部